These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23009611)

  • 21. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
    Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
    Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Cu(II) coordination compounds on the activity of antioxidant enzymes catalase and superoxide dismutase in patients with colorectal cancer.
    Kubiak K; Malinowska K; Langer E; Dziki Ł; Dziki A; Majsterek I
    Pol Przegl Chir; 2011 Mar; 83(3):155-60. PubMed ID: 22166318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chromosome anomaly and flow cytometry in gallbladder adenocarcinoma].
    Sanz P; Calvo A; Tobella L; Salazar S; Daher V; Castillo S; Nielsen E; Smok G; Csendes A; Serra I
    Rev Med Chil; 1998 Nov; 126(11):1301-10. PubMed ID: 10349172
    [No Abstract]   [Full Text] [Related]  

  • 25. Superoxide dismutase and catalase blood levels in patients with malignant diseases.
    Casado A; de la Torre R; López-Fernández ME; Carrascosa D; Casado MC; Ramírez MV
    Cancer Lett; 1995 Jul; 93(2):187-92. PubMed ID: 7621427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic alterations in gallbladder carcinoma.
    Kuroki T; Tajima Y; Matsuo K; Kanematsu T
    Surg Today; 2005; 35(2):101-5. PubMed ID: 15674488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in serum antioxidant concentrations during infection with caprine lentivirus.
    Mdurvwa EG; Ogunbiyi PO; Reddy PG; Gakou HS; Sodeke SO; Carty AJ
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S65-72. PubMed ID: 8574149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the anti-oxidant enzyme activities of blood fractions and the yield of bleomycin-induced chromosome damage.
    Larramendy ML; Bianchi MS; Padrón J
    Mutat Res; 1989 Sep; 214(1):129-36. PubMed ID: 2475771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease.
    Pandey SN; Modi DR; Choudhuri G; Mittall B
    Cancer Biol Ther; 2007 Jan; 6(1):91-6. PubMed ID: 17224641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antioxidant enzymes in the control of opossum gallbladder motility.
    Cullen JJ; Conklin JL; Ephgrave KS; Oberley LW
    J Surg Res; 1999 Sep; 86(1):155-61. PubMed ID: 10452883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum biochemical markers in carcinoma breast.
    Seth LR; Kharb S; Kharb DP
    Indian J Med Sci; 2003 Aug; 57(8):350-4. PubMed ID: 12944692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinogen Metabolism Pathway and Tumor Suppressor Gene Polymorphisms and Gallbladder Cancer Risk in North Indians: A Hospital-Based Case-Control Study.
    Asai T; Tsuchiya Y; Mishra K; Behari A; Shukla P; Ikoma T; Kapoor VK; Nakamura K
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3643-3647. PubMed ID: 31870105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma.
    Deblakshmi RK; Deka M; Saikia AK; Sharma BK; Singh N; Das NN; Bose S
    Asian Pac J Cancer Prev; 2015; 16(7):2923-8. PubMed ID: 25854384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors and etiopathogenesis of cancer of the gallbladder].
    Seccia M; Cavina E
    Ann Ital Chir; 1989; 60(3):163-71; discussion 172. PubMed ID: 2694881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
    Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
    Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single exposure to hyperbaric oxygen does not cause oxidative stress in isolated platelets: no effect on superoxide dismutase, catalase, or cellular ATP.
    Shaw FL; Handy RD; Bryson P; Sneyd JR; Moody AJ
    Clin Biochem; 2005 Aug; 38(8):722-6. PubMed ID: 15946662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
    Chang HJ; Kim SW; Kim YT; Kim WH
    Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of maspin mRNA as a predictor of survival in stage II and III gallbladder cancer cases.
    Baghel K; Kazmi HR; Raj S; Chandra A; Srivastava RN
    Asian Pac J Cancer Prev; 2014; 15(1):343-7. PubMed ID: 24528054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
    Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
    J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.